Catheter re-dose may tame pain and nausea after Weight-Loss surgery

NCT ID NCT07655908

Not yet recruiting Symptom relief Sponsor: Universidad Simón Bolívar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a temporary catheter placed during laparoscopic sleeve gastrectomy can be used to re-dose nerve-blocking medicine (bupivacaine and dexamethasone) if severe pain or nausea break through after surgery. It includes 30 high-risk patients, such as young women or those with a history of severe post-surgery symptoms. The goal is to see if this approach is safe, feasible, and effective at reducing pain and nausea without needing extra opioids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine and dexamethasone
What this could lead to: If it works, this approach could offer a way to manage severe pain and nausea after gastric sleeve surgery without relying on opioids.
What could go wrong: This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The catheter placement itself carries risks like infection or blockage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NAUSEA AND VOMITING, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Pain, Postoperative Postoperative Nausea and Vomiting Visceral Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NAUSEA AND VOMITING, POSTOPERATIVE PAIN, ACUTE POST-OPERATIVE

More trials for these conditions

Other studies related to the condition(s) this trial covers.